{"transactions":[{"id":730398,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T20:25:54.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":49579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":49579,"derivative":{"exercise_price":1.13,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":49579},"source":{"system":"sec-edgar","filing":"0000905148-26-003052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514826003052/form4.xml","form_type":"4"}},{"id":730397,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:25:54.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":111310,"source":{"system":"sec-edgar","filing":"0000905148-26-003052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514826003052/form4.xml","form_type":"4"}},{"id":731887,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:57:28.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":66350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":66350,"derivative":{"exercise_price":2.48,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":66350},"source":{"system":"sec-edgar","filing":"0001610717-26-000272","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000161071726000272/form4.xml","form_type":"4"}},{"id":776918,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T20:31:21.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15757},"source":{"system":"sec-edgar","filing":"0001405692-26-000002","document":"form4-05152026_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000140569226000002/form4-05152026_080516.xml","form_type":"4"}},{"id":776917,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:31:21.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2025, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 14, 2026, the day of the issuer's annual meeting."}],"balance_after":51846,"source":{"system":"sec-edgar","filing":"0001405692-26-000002","document":"form4-05152026_080516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000140569226000002/form4-05152026_080516.xml","form_type":"4"}},{"id":1103615,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T22:38:24.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50790,"derivative":{"exercise_price":2.11,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":50790},"source":{"system":"sec-edgar","filing":"0000905148-25-002231","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514825002231/form4.xml","form_type":"4"}},{"id":1103614,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-23T22:38:24.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":29210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":80889,"source":{"system":"sec-edgar","filing":"0000905148-25-002231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514825002231/form4.xml","form_type":"4"}},{"id":1113180,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-12T23:28:56.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":112157,"source":{"system":"sec-edgar","filing":"0000905148-25-002128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514825002128/form4.xml","form_type":"4"}},{"id":1136929,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-22T21:01:50.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":15757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 21, 2025, under the 2020 Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":15757,"derivative":{"underlying":"Common Stock","underlying_shares":15757},"source":{"system":"sec-edgar","filing":"0001415889-25-014189","document":"form4-05222025_090546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588925014189/form4-05222025_090546.xml","form_type":"4"}},{"id":1136928,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-22T21:01:50.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11928},"source":{"system":"sec-edgar","filing":"0001415889-25-014189","document":"form4-05222025_090546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588925014189/form4-05222025_090546.xml","form_type":"4"}},{"id":1136927,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:01:50.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 21, 2024, under the Certara, Inc. 2020 Incentive Plan (\"2020 Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2025, the day of the issuer's annual meeting."}],"balance_after":36089,"source":{"system":"sec-edgar","filing":"0001415889-25-014189","document":"form4-05222025_090546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588925014189/form4-05222025_090546.xml","form_type":"4"}},{"id":1186314,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-01T16:39:38.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":71174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":71174,"source":{"system":"sec-edgar","filing":"0000905148-25-001032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514825001032/form4.xml","form_type":"4"}},{"id":1306650,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T14:14:20.000Z","date":"2025-01-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount, but less than $13.00 (any such option, an \"Underwater Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Underwater Option was not entitled to any payment of the Cash Amount in respect thereof and each Underwater Option was converted into the right to receive the CVR included in the Option Consideration  with respect to each Share underlying such Underwater Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (a) the total number of Shares underlying such Underwater Option, multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the amount of such milestone payment plus the amount of any other milestone payments that previously became due and payable under the terms of the CVR Agreement exceeds (2) the exercise price per Share with respect to such Underwater Option plus the Milestone Payment Amounts (as such term is defined in the CVR Agreement), [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, previously paid pursuant to the CVR Agreement in respect of each CVR granted in respect of such Underwater Option; provided further, that any Option with an exercise price that was equal to or greater than $13.00, was cancelled immediately prior to the effective time of the Merger without any payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":2.81,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":27350},"source":{"system":"sec-edgar","filing":"0001415889-25-001086","document":"form4-01082025_070116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000141588925001086/form4-01082025_070116.xml","form_type":"4"}},{"id":1306649,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T14:14:20.000Z","date":"2025-01-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount, but less than $13.00 (any such option, an \"Underwater Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Underwater Option was not entitled to any payment of the Cash Amount in respect thereof and each Underwater Option was converted into the right to receive the CVR included in the Option Consideration  with respect to each Share underlying such Underwater Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (a) the total number of Shares underlying such Underwater Option, multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the amount of such milestone payment plus the amount of any other milestone payments that previously became due and payable under the terms of the CVR Agreement exceeds (2) the exercise price per Share with respect to such Underwater Option plus the Milestone Payment Amounts (as such term is defined in the CVR Agreement), [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, previously paid pursuant to the CVR Agreement in respect of each CVR granted in respect of such Underwater Option; provided further, that any Option with an exercise price that was equal to or greater than $13.00, was cancelled immediately prior to the effective time of the Merger without any payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":2.47,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":27350},"source":{"system":"sec-edgar","filing":"0001415889-25-001086","document":"form4-01082025_070116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000141588925001086/form4-01082025_070116.xml","form_type":"4"}},{"id":1306648,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T14:14:20.000Z","date":"2025-01-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount, but less than $13.00 (any such option, an \"Underwater Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Underwater Option was not entitled to any payment of the Cash Amount in respect thereof and each Underwater Option was converted into the right to receive the CVR included in the Option Consideration  with respect to each Share underlying such Underwater Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (a) the total number of Shares underlying such Underwater Option, multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the amount of such milestone payment plus the amount of any other milestone payments that previously became due and payable under the terms of the CVR Agreement exceeds (2) the exercise price per Share with respect to such Underwater Option plus the Milestone Payment Amounts (as such term is defined in the CVR Agreement), [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, previously paid pursuant to the CVR Agreement in respect of each CVR granted in respect of such Underwater Option; provided further, that any Option with an exercise price that was equal to or greater than $13.00, was cancelled immediately prior to the effective time of the Merger without any payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001415889-25-001086","document":"form4-01082025_070116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000141588925001086/form4-01082025_070116.xml","form_type":"4"}},{"id":1306647,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T14:14:20.000Z","date":"2025-01-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":87440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option (the \"Option Consideration\"); provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount, but less than $13.00 (any such option, an \"Underwater Option\"), [continues to Footnote 4]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"[Continues from Footnote 3] such Underwater Option was not entitled to any payment of the Cash Amount in respect thereof and each Underwater Option was converted into the right to receive the CVR included in the Option Consideration  with respect to each Share underlying such Underwater Option and became entitled to receive, at each time a milestone payment becomes due and payable under the terms of the CVR Agreement, an amount in cash equal to the product of (a) the total number of Shares underlying such Underwater Option, multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the amount of such milestone payment plus the amount of any other milestone payments that previously became due and payable under the terms of the CVR Agreement exceeds (2) the exercise price per Share with respect to such Underwater Option plus the Milestone Payment Amounts (as such term is defined in the CVR Agreement), [continues to Footnote 5]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"[Continues from Footnote 4] if any, previously paid pursuant to the CVR Agreement in respect of each CVR granted in respect of such Underwater Option; provided further, that any Option with an exercise price that was equal to or greater than $13.00, was cancelled immediately prior to the effective time of the Merger without any payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.63,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":87440},"source":{"system":"sec-edgar","filing":"0001415889-25-001086","document":"form4-01082025_070116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000141588925001086/form4-01082025_070116.xml","form_type":"4"}},{"id":1306646,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T14:14:20.000Z","date":"2025-01-08","kind":"other","planned":false,"acquired":false,"shares":58950,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 25, 2024, by and among Poseida Therapeutics, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Blue Giant Acquisition Corp., a wholly owned subsidiary of Parent (\"Merger Sub\").  On January 8, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $9.00 per Share in cash (the \"Cash Amount\"), and (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $4.00 per Share, [continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] in cash, upon the achievement of specified milestones, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\").  Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 25, 2024, by and among Poseida Therapeutics, Inc. (the \"Issuer\"), Roche Holdings, Inc. (\"Parent\") and Blue Giant Acquisition Corp., a wholly owned subsidiary of Parent (\"Merger Sub\").  On January 8, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $9.00 per Share in cash (the \"Cash Amount\"), and (ii) one non-tradeable contingent value right (each, a \"CVR\") representing the right to receive certain contingent payments of up to an aggregate amount of $4.00 per Share, [continues to Footnote 2]"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"[continues from Footnote 1] in cash, upon the achievement of specified milestones, subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\").  Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001086","document":"form4-01082025_070116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000141588925001086/form4-01082025_070116.xml","form_type":"4"}},{"id":1385786,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-10-16T21:36:05.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":97698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares underlying this option shall vest on October 14, 2025, and the remainder shall vest in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":97698,"derivative":{"exercise_price":3.87,"expiration_date":"2034-10-13","underlying":"Common Stock","underlying_shares":97698},"source":{"system":"sec-edgar","filing":"0000905148-24-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514824002726/form4.xml","form_type":"4"}},{"id":1385785,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-16T21:36:05.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":51679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One hundred percent (100%) of the RSUs shall vest on October 14, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51679,"source":{"system":"sec-edgar","filing":"0000905148-24-002726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000090514824002726/form4.xml","form_type":"4"}},{"id":1475304,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-18T16:14:32.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":27350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":27350,"derivative":{"exercise_price":2.81,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":27350},"source":{"system":"sec-edgar","filing":"0000950170-24-074865","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000095017024074865/ownership.xml","form_type":"4"}},{"id":1475303,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T16:14:32.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":19650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":58950,"source":{"system":"sec-edgar","filing":"0000950170-24-074865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000095017024074865/ownership.xml","form_type":"4"}},{"id":1503510,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-23T20:29:35.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":11928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU was granted on May 21, 2024, under the Incentive Plan that entitles the reporting person to receive one share of issuer's common stock per RSU. The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual meeting."}],"balance_after":11928,"derivative":{"underlying":"Common Stock","underlying_shares":11928},"source":{"system":"sec-edgar","filing":"0001415889-24-014263","document":"form4-05232024_080526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588924014263/form4-05232024_080526.xml","form_type":"4"}},{"id":1503509,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-23T20:29:35.000Z","date":"2024-05-21","kind":"exercise","planned":false,"acquired":false,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8663},"source":{"system":"sec-edgar","filing":"0001415889-24-014263","document":"form4-05232024_080526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588924014263/form4-05232024_080526.xml","form_type":"4"}},{"id":1503508,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T20:29:35.000Z","date":"2024-05-21","kind":"exercise","planned":false,"acquired":true,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") was granted on May 23, 2023, under Certara, Inc.'s 2020 Incentive Plan (\"Incentive Plan\") entitling the reporting person to receive one share of the issuer's common stock per RSU. The RSUs vested and were converted to common stock on May 21, 2024, the day of the issuer's annual meeting."}],"balance_after":24161,"source":{"system":"sec-edgar","filing":"0001415889-24-014263","document":"form4-05232024_080526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588924014263/form4-05232024_080526.xml","form_type":"4"}},{"id":1852219,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-16T16:10:31.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":27350,"derivative":{"exercise_price":2.47,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":27350},"source":{"system":"sec-edgar","filing":"0000950170-23-028609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000095017023028609/ownership.xml","form_type":"4"}},{"id":1852218,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T16:10:31.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":19650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":39300,"source":{"system":"sec-edgar","filing":"0000950170-23-028609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000095017023028609/ownership.xml","form_type":"4"}},{"id":1866744,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:45:19.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service.  The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024."}],"balance_after":104835,"source":{"system":"sec-edgar","filing":"0001209191-23-034623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919123034623/doc4.xml","form_type":"4"}},{"id":1877910,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-25T12:41:45.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":8663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 23, 2023, under the Certara Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 23, 2023, under the Certara Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 23, 2023, under the Certara Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the issuer's common stock per RSU.  The RSUs vest on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual shareholder meeting."}],"balance_after":8663,"derivative":{"underlying":"Common Stock","underlying_shares":8663},"source":{"system":"sec-edgar","filing":"0001415889-23-008748","document":"form4-05252023_120541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588923008748/form4-05252023_120541.xml","form_type":"4"}},{"id":1884381,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T12:34:11.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":9067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9067},"source":{"system":"sec-edgar","filing":"0001415889-23-008304","document":"form4-05192023_120506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588923008304/form4-05192023_120506.xml","form_type":"4"}},{"id":1884380,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T12:34:11.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":9067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted under the Certara, Inc. 2020 Incentive Plan that entitles the reporting person to receive one share of the Issuer's Common Stock per RSU.  The RSUs vested and were converted into common shares on the one-year anniversary of the date of grant."}],"balance_after":15498,"source":{"system":"sec-edgar","filing":"0001415889-23-008304","document":"form4-05192023_120506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588923008304/form4-05192023_120506.xml","form_type":"4"}},{"id":2227847,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T10:44:08.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":28500,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-22-037711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919122037711/doc4.xml","form_type":"4"}},{"id":2227846,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T10:44:08.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":19650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":19650,"source":{"system":"sec-edgar","filing":"0001209191-22-037711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919122037711/doc4.xml","form_type":"4"}},{"id":2251242,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T01:01:23.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":26480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service.  The shares underlying any vested restricted stock units shall be released to the reporting person on May 26, 2023."}],"balance_after":69121,"source":{"system":"sec-edgar","filing":"0001209191-22-033016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919122033016/doc4.xml","form_type":"4"}},{"id":2265489,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-18T20:37:25.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":9067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting."}],"balance_after":9067,"derivative":{"underlying":"Common Stock","underlying_shares":9067},"source":{"system":"sec-edgar","filing":"0001415889-22-005245","document":"form4-05182022_010540.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588922005245/form4-05182022_010540.xml","form_type":"4"}},{"id":2617411,"issuer":{"id":787,"kind":"organization","name":"Certara, Inc.","symbol":"CERT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T20:46:06.000Z","date":"2021-08-01","kind":"grant","acquired":true,"shares":6431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 6,431 restricted stock units (\"RSU\") granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual stockholder meeting."}],"balance_after":6431,"source":{"system":"sec-edgar","filing":"0001415889-21-003770","document":"form4-08032021_010824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000141588921003770/form4-08032021_010824.xml","form_type":"4"}},{"id":2624913,"issuer":{"id":84243,"kind":"organization","name":"Poseida Therapeutics, Inc.","symbol":"PSTX"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-26T20:29:21.000Z","date":"2021-07-23","kind":"grant","acquired":true,"shares":87440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable in 36 equal monthly installments following the grant date set forth in column 3 above."}],"balance_after":87440,"derivative":{"exercise_price":8.63,"expiration_date":"2031-07-23","underlying":"Common Stock","underlying_shares":87440},"source":{"system":"sec-edgar","filing":"0001209191-21-048255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661460/000120919121048255/doc4.xml","form_type":"4"}},{"id":2691087,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-29T00:15:00.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":4661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest, and the shares underlying the restricted stock units shall be released to the reporting person, on January 1, 2023, subject to the reporting person's continued service."}],"balance_after":42641,"source":{"system":"sec-edgar","filing":"0001209191-21-036708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919121036708/doc4.xml","form_type":"4"}},{"id":2691086,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-29T00:15:00.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":4497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service.  The shares underlying any vested restricted stock units shall be released to the reporting person on January 3, 2023."}],"balance_after":37980,"source":{"system":"sec-edgar","filing":"0001209191-21-036708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919121036708/doc4.xml","form_type":"4"}},{"id":2868939,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-02-10T21:26:39.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":1262,"price":66.65,"value":84112.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 6, 2021. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $66.47 to $66.66. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":43760,"source":{"system":"sec-edgar","filing":"0001179110-21-001512","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911021001512/edgar.xml","form_type":"4"}},{"id":3049808,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-08-21T20:12:23.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":1976,"price":36.66,"value":72440.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 19, 2020. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $36.44 to $36.66. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45022,"source":{"system":"sec-edgar","filing":"0001179110-20-009219","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911020009219/edgar.xml","form_type":"4"}},{"id":3104176,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T20:13:14.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. All of the restricted stock units shall vest in a single installment on June 17, 2021, subject to the reporting person's continued service through the earlier to occur of (i) June 17, 2021 or (ii) the date of the issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":33483,"source":{"system":"sec-edgar","filing":"0001209191-20-037910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919120037910/doc4.xml","form_type":"4"}},{"id":3281899,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-10T21:32:04.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 6, 2020 and is scheduled to vest over four years in equal monthly installments beginning on March 6, 2020 through February 6, 2024."}],"balance_after":93750,"derivative":{"exercise_price":28.05,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001179110-20-001362","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911020001362/edgar.xml","form_type":"4"}},{"id":3281898,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-10T21:32:04.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on February 6, 2021 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2024."}],"balance_after":46998,"source":{"system":"sec-edgar","filing":"0001179110-20-001362","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911020001362/edgar.xml","form_type":"4"}},{"id":3294801,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T21:07:06.000Z","date":"2020-01-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, all of the restricted stock units shall vest in a single installment on the date of the 2020 annual meeting of the stockholders of the issuer."}],"balance_after":25483,"source":{"system":"sec-edgar","filing":"0001209191-20-005975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919120005975/doc4.xml","form_type":"4"}},{"id":3322527,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-01-03T17:04:25.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":8755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on\nDecember 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on\nDecember 31, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8755},"source":{"system":"sec-edgar","filing":"0001209191-20-000596","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919120000596/doc4.xml","form_type":"4"}},{"id":3322526,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T17:04:25.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":8755,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":19483,"source":{"system":"sec-edgar","filing":"0001209191-20-000596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000120919120000596/doc4.xml","form_type":"4"}},{"id":3414903,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-13T20:06:04.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 11, 2019 and is scheduled to vest as to one-third of the shares underlying the option when the closing price of the Issuer's common stock, as reported on the Nasdaq Global Select Market, has for 15 consecutive trading days equaled or exceeded $50.00, $75.00 and $100.00 per share, respectively."}],"balance_after":250000,"derivative":{"exercise_price":26.57,"expiration_date":"2024-08-19","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001179110-19-010316","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019010316/edgar.xml","form_type":"4"}},{"id":3414902,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-13T20:06:04.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on September 11, 2019 and is scheduled to vest over four years, with 25% of the shares to vest on August 19, 2020 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 19, 2023."}],"balance_after":500000,"derivative":{"exercise_price":26.57,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001179110-19-010316","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019010316/edgar.xml","form_type":"4"}},{"id":3414901,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-09-13T20:06:04.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 19, 2019 through August 19, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 19, 2019 through August 19, 2022."}],"balance_after":31373,"source":{"system":"sec-edgar","filing":"0001179110-19-010316","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019010316/edgar.xml","form_type":"4"}},{"id":3431986,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:03:45.000Z","date":"2019-08-19","kind":"sale","acquired":false,"shares":5193,"price":25.83,"value":134135.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a durable automatic sales instruction letter entered into between the Reporting Person and the issuer in connection with the Reporting Person receiving restricted stock unit awards from the issuer, and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 19, 2019. The sales do not represent a discretionary trade by the Reporting Person."}],"balance_after":11373,"source":{"system":"sec-edgar","filing":"0001179110-19-009744","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019009744/edgar.xml","form_type":"4"}},{"id":3431985,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-21T20:03:45.000Z","date":"2019-08-19","kind":"grant","acquired":true,"shares":8283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported transaction involved the Reporting Peron's receipt of 8,283 shares of common stock on August 19, 2019 in connection with the vesting of a restricted stock unit award. Such amount includes (i) 8,283 shares of common stock received by the Reporting Person on August 19, 2019 that was previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 4, 2019 and (ii) 8,283 shares of common stock received by the Reporting Person in connection with a restricted stock unit award that was previously reported in Table 1 of a Form 4 filed by the Reporting Person with the SEC on August 7, 2019."}],"balance_after":16566,"source":{"system":"sec-edgar","filing":"0001179110-19-009744","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019009744/edgar.xml","form_type":"4"}},{"id":3444470,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-07T20:16:35.000Z","date":"2019-08-06","kind":"grant","acquired":true,"shares":8283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest in its entirety on the earlier of (i) the termination of the engagement of the Reporting Person as an interim Chief Executive Officer of Editas Medicine, Inc. and (ii) December 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest in its entirety on the earlier of (i) the termination of the engagement of the Reporting Person as an interim Chief Executive Officer of Editas Medicine, Inc. and (ii) December 31, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Such amount includes common stock to be received by the Reporting Person on or about August 19, 2019 in connection with the anticipated vesting of a Restricted Stock Unit award granted to the Reporting Person and previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 4, 2019."}],"balance_after":16566,"source":{"system":"sec-edgar","filing":"0001179110-19-009249","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019009249/edgar.xml","form_type":"4"}},{"id":3489433,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:26:03.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2019 and is scheduled to vest in full on June 12, 2020."}],"balance_after":11538,"derivative":{"exercise_price":21.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-19-007669","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019007669/edgar.xml","form_type":"4"}},{"id":3677272,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-02-04T22:36:45.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":8283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award is scheduled to vest in its entirety on the earlier of (i) July 31, 2019, (ii) the appointment by the Board of Directors of Editas Medicine, Inc. (the \"Company\") of a permanent chief executive officer or (iii) the termination of a consulting agreement entered into by the Reporting Person and the Company (the \"Trigger Date\"). On the Trigger Date, all shares will be delivered to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award is scheduled to vest in its entirety on the earlier of (i) July 31, 2019, (ii) the appointment by the Board of Directors of Editas Medicine, Inc. (the \"Company\") of a permanent chief executive officer or (iii) the termination of a consulting agreement entered into by the Reporting Person and the Company (the \"Trigger Date\"). On the Trigger Date, all shares will be delivered to the Reporting Person."}],"balance_after":8283,"derivative":{"underlying":"Common Stock","underlying_shares":8283},"source":{"system":"sec-edgar","filing":"0001179110-19-001239","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911019001239/edgar.xml","form_type":"4"}},{"id":3737494,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":36312,"kind":"person","name":"Collins Cynthia","position":1,"cik":"0001405692","reported_name":"Collins Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-10T14:14:18.000Z","date":"2018-12-06","kind":"grant","acquired":true,"shares":23076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 6, 2018 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on December 6, 2019 through December 6, 2021."}],"balance_after":23076,"derivative":{"exercise_price":29.69,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":23076},"source":{"system":"sec-edgar","filing":"0001179110-18-013609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405692/000117911018013609/edgar.xml","form_type":"4"}}]}